Isaac Scientific Publishing
Modern Clinical Medicine Research
MCMR > Volume 1, Number 2, July 2017

Effects of Unbalanced Polyunsaturated Fatty Acid Intake on Obesity-related Metabolic and Hepatic Dysfunctions

Download PDF  (180.7 KB)PP. 43-47,  Pub. Date:July 19, 2017
DOI: 10.22606/mcmr.2017.12002

Author(s)
Giorgio Ricci, Edgardo Canducci, Ada Guida, Rosario Arena, Ambra Frascari, Bruna Ravani, Vittorio Alvisi
Affiliation(s)
Postgraduate School of Gastroenterology, Section of Endocrinology and Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy;; Clinical Nutrition, Section of Internal & Cardiopulmonary Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy;; Postgraduate School of Gastroenterology, Section of Endocrinology and Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy;; Postgraduate School of Gastroenterology, Section of Endocrinology and Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy;; Postgraduate School of Gastroenterology, Section of Endocrinology and Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy;; Clinical Nutrition, Section of Internal & Cardiopulmonary Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy;; Internal Medicine Unit, Malatesta Novello Hospital, Via R. Serra 2, 47521 Cesena, Italy
Abstract
In obesity, BARD (BMI, AST/ALT Ratio, presence of Diabetes) score, positive for values ≥2, is a non-invasive marker of liver fibrosis. Unbalanced dietary habits are related to metabolic and liver dysfunctions. The aims were to investigate in Italian obese patients the prevalence of insulin resistance (IR) and positive BARD; the evaluation of excessive, or deficient, nutrient intakes and their relationship with IR and/or liver fibrosis. From the 220 records, 198 obese patients were included. Anthropometric measurements, HOMA-IR, BARD score and the nutrient intakes, as variances over or below the Recommended Dietary Allowances (RDAs) by the dietary assessment, were calculated as 50th (25th, 75th) percentile. HOMA-IR was in 68% averaging 3.53 (2.26, 5.66), and positive BARD in 42%. Excessive ω-6 fatty acid intake was associated with high and significant risk (OR 5.01) of IR, as well as of liver fibrosis (OR 5.67). Excessive ω-6 fatty acid intake enhances ω-6- derived eicosanoids, inducing liver inflammation and fibrosis.
Keywords
Italian obese patients, dietary habits, omega-6 fatty acid, polyunsaturated fatty acid, liver fibrosis marker, insulin resistance
References
  • [1]  A. Berlanga, E. Guiu-Jurado, J.A. Porras, and T. Augue, “Molecular pathways in non-alcoholic fatty liver disease”. Clinical Experimental Gastroenterology; vol. 7, pp. 221-239, 2014.
  • [2]  P. Dietrich and C. Hellerbrand, “Non-alcoholic fatty liver disease, obesity and the metabolic syndrome” Best Practice & Research Clinical Gastroenterology, vol. 28, no. 4, pp. 637-653, 2014.
  • [3]  C.F. Subasi, U.E. Aykut and Y. Yilmaz, “Comparison of noninvasive scores for the detection of advanced fibrosis in patients with nonalcoholic fatty liver disease” European Journal Gastroenterology & Hepatology, vol. 27, no. 2, pp. 137-141, 2015.
  • [4]  S.A. Harrison, D. Oliver, H.L. Arnold, S Gogia and B.A. Neuschwander-Tetri, “Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease” Gut, vol.57, no.10, pp.1441-1447, 2008.
  • [5]  N.C. Chavez-Tapia and C. Tiribelli, “Are non-invasive tests accurate enough to predict hepatic fibrosis in nonalcoholic fatty liver disease (NAFLD)?” Gut, vol. 57, no. 10, pp. 1351-1353, 2008.
  • [6]  E.M. McCarthy and M.E. Rinella, “The role of diet and nutrient composition in nonalcoholic fatty liver disease” Journal of Academy of Nutrition and Dietetics, vol. 112, no. 3, pp. 401-409, 2012.
  • [7]  G. Ricci, E. Canducci, V. Pasini, A. Rossi, G. Bersani, E. Ricci and V. Alvisi, “Nutrient intake in Italian obese patients: relationships with insulin resistance and markers of non-alcoholic fatty liver disease” Nutrition, vol. 27, no. 6, pp. 672-676, 2011.
  • [8]  G. Ricci, E. Canducci, A. Guida, A. Frascari, A. Rossi, G. Bersani, B. Ravani and V. Alvisi, “The gender-related differences of nutrient intakes in a group of Italian obese patients display the ongoing transition from Mediterranean to western dietary patterns” Obesity Surgery, vol. 24, no. 6 , pp. 965-967, 2014.
  • [9]  A. Borai, C. Livingstone, I. Kaddam and G. Ferns, “Selection of the appropriate method for the assessment of insulin resistance” BMC Medical Research Methodology, vol. 11, pp. 158, 2011.
  • [10]  E. Carnovale and L. Marletta, Tabelle di composizione degli alimenti. Ed EDRA, INRAN, Rome, Italy, 2000.
  • [11]  M. Nelson, M. Atkinson and S. Darbyshire, “Food photography II: use of food photographs for estimating portion size and the nutrient content of meals” British Journal of Nutrition, vol. 76, no. 1, pp. 31-49, 1996.
  • [12]  Società Italiana di Nutrizione Umana (S.I.N.U.). Livelli di Assunzione Raccomandati di Energia e Nutrienti per la Popolazione Italiana (LARN), IV revisione, SICS, Milan, Italy, 2014.
  • [13]  V. Ratziu, S. Bellentani, H. Cortez-Pinto, C. Day and G. Marchesini, “A position statement on NAFLD/NASH based on the EASL 2009 special conference” Journal of Hepatology, vol. 53, no. 2, pp. 372-384, 2010.
  • [14]  K.A. Lê and M. Bortolotti, “Role of dietary carbohydrates and macronutrients in the pathogenesis of nonalcoholic fatty liver disease” Current Opinion in Clinical Nutrition & Metabolic Care, vol. 11, no. 4, pp. 477-482, 2008.
  • [15]  C. Gonzalez, V. de Ledinghen, J. Vergniol, J. Foucher, B. Le Bail, S. Carlier, E. Maury, H. Gin and V. Rigalleau“Hepatic steatosis, carbohydrate intake, and food quotient in patients with NAFLD” International Journal of Endocrinology, 428542. Published online, May 2, 2013.
  • [16]  E.M. Inelmen, E.D. Toffanello, G. Enzi, G. Sergi, A. Coin, L. Busetto and E. Manzato, “Differences in dietary patterns between older and younger obese and overweight outpatients” The journal of nutrition, health & aging, vol. 12, no. 1, pp.3-8, 2008.
  • [17]  L. Abenavoli, N. Milic, V. Peta, F. Alfieri, A. De Lorenzo and S. Bellentani, “Alimentary regimen in nonalcoholic fatty liver disease: Mediterranean diet” World Journal of Gastroenterology, vol. 20, no. 45, pp. 16831-16840, 2014.
  • [18]  B. Elisha, F. Guebre-Egziabher, H Vidal, J.P. Bastard, M. Laville and R. Rabasa-Lhoret, “From French to Mediterranean diet: importance of the omega-6/omega-3 fatty acids ratio” World Review of Nutrition and Dietetics, vol. 102, pp. 81-91, 2011.
  • [19]  J. Monteiro, M. Leslie, M.H. Moghadasian, B.M. Arendt, J.P. Allard, D.W. Ma, “The role of n - 6 and n - 3 polyunsaturated fatty acids in the manifestation of the metabolic syndrome in cardiovascular disease and nonalcoholic fatty liver disease” Food & Function, vol. 5, pp. 426-435, 2014.
  • [20]  A.P. Simopoulous, “An increase in the Omega-6/Omega-3 fatty acid ratio increases the risk of obesity” Nutrients, vol. 8, no. 3, pp. 128, 2016.
Copyright © 2017 Isaac Scientific Publishing Co. All rights reserved.